Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 1
1986 3
1988 4
1989 3
1994 4
1995 2
1996 4
1999 2
2000 2
2001 4
2002 2
2006 1
2007 2
2008 1
2009 2
2010 3
2011 3
2012 3
2013 6
2014 3
2015 4
2016 1
2017 2
2018 4
2019 7
2020 6
2021 2
2022 2
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

81 results

Results by year

Filters applied: . Clear all
Page 1
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.
Bang YJ, Van Cutsem E, Feyereislova A, Chung HC, Shen L, Sawaki A, Lordick F, Ohtsu A, Omuro Y, Satoh T, Aprile G, Kulikov E, Hill J, Lehle M, Rüschoff J, Kang YK; ToGA Trial Investigators. Bang YJ, et al. Lancet. 2010 Aug 28;376(9742):687-97. doi: 10.1016/S0140-6736(10)61121-X. Epub 2010 Aug 19. Lancet. 2010. PMID: 20728210 Clinical Trial.
G-protein-coupled receptor function in heart failure.
Prasad SV, Nienaber J, Rockman HA. Prasad SV, et al. Cold Spring Harb Symp Quant Biol. 2002;67:439-44. doi: 10.1101/sqb.2002.67.439. Cold Spring Harb Symp Quant Biol. 2002. PMID: 12858569 Review. No abstract available.
Nanoantibiotics containing membrane-active human cathelicidin LL-37 or synthetic ceragenins attached to the surface of magnetic nanoparticles as novel and innovative therapeutic tools: current status and potential future applications.
Wnorowska U, Fiedoruk K, Piktel E, Prasad SV, Sulik M, Janion M, Daniluk T, Savage PB, Bucki R. Wnorowska U, et al. Among authors: prasad sv. J Nanobiotechnology. 2020 Jan 2;18(1):3. doi: 10.1186/s12951-019-0566-z. J Nanobiotechnology. 2020. PMID: 31898542 Free PMC article. Review.
Ethnicity and breast cancer characteristics in Kenya.
Sayed S, Moloo Z, Wasike R, Bird P, Oigara R, Njoroge FW, Shaikh AJ, Prasad SV, Vinayak S, Gierach GL, Dawsey SM, Palakal M, Fan S, Mullooly M, Chauhan R, Okiro P, Gakinya S, Nzioka A, Kyobutungi C, Mohamed S, Haregu T, Mussajee M, Bonass B, Mariwa C, Sherman OA, Mohammed A, Gachii A, Githaiga J, Karanu J, Nyagah R, Njoroge R, Muramba I, Otieno JO, Raburu DO, Mwachiro EB, Abayo I, Saleh M. Sayed S, et al. Among authors: prasad sv. Breast Cancer Res Treat. 2018 Jan;167(2):425-437. doi: 10.1007/s10549-017-4511-2. Epub 2017 Sep 26. Breast Cancer Res Treat. 2018. PMID: 28951987 Free PMC article.
81 results